Sign in

Trial site

Ruppiner Kliniken GmbH

Neuruppin, 16816, GermanyNot linked to an institution yet
  • 3running trials
  • 2closed trials

The trials here

What the 5 trials at this site are about, from their registry records.

Phase
  • Phase 33 trials
  • Phase 21 trial
  • Phase 2/31 trial
Status
  • Recruiting3 trials
  • Completed2 trials
Lead sponsor
  • AstraZeneca2 trials
  • Dr. Falk Pharma GmbH1 trial
  • Mirati Therapeutics Inc.1 trial
  • Opella Healthcare Group S.A.S.1 trial

Running trials

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Site data: ClinicalTrials.govUpdated 13 Nov 2026